Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Inv. presentation
Quarterly results
Director departure
|
|
Acutus Medical, Inc. (AFIB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 433 shares
@ $0.69, valued at
$298.8 |
|
| 08/07/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 134 shares
@ $0.69, valued at
$92.5 |
|
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 08/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 6,484 shares
@ $0 |
|
| 08/02/2023 |
4
| Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 501 shares
@ $0 |
|
| 07/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/29/2023 |
4/A
| ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Marzouk Shaden (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Sheridan John F (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Bonita David P (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 10,920 shares
@ $0
Granted 25,480 options to buy
@ $0.8349, valued at
$21.3k
|
|
| 06/15/2023 |
4
| ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Pellegrini Niamh Louise (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/01/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 17,290 shares
@ $0.8479, valued at
$14.7k
|
|
| 05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/05/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 321 shares
@ $0.754, valued at
$242 |
|
| 04/04/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,165 shares
@ $0.754, valued at
$2.4k
|
|
| 04/04/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
| 04/04/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
| 03/16/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Other Events |
| 03/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
| 03/02/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
| 03/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 135,000 shares
@ $0
Granted 135,000 options to buy
@ $1.41, valued at
$190.4k
|
|
|
|
|